Insights+: COVID-19 Healthcare News Monthly Updates – September 2020
Shots: The MAA submission follows the results of P-II DELPHI study, DELPHI-Extension study, P-III DELOS (1-5) study and SYROS study. The collective studies result demonstrated that Puldysa (idebenone) is showing clinical benefits & long-term efficacy in patients with DMD Santhera also plans to submit NDA to the FDA following the completion of P-III SIDEROS study […]Read More
